Efficacy and safety of entecavir versus lamivudine over 5 years of treatment: A randomized controlled trial in Korean patients with hepatitis B e antigen-negative chronic hepatitis B
2017 ◽
Vol 23
(4)
◽
pp. 331-339
◽
2008 ◽
Vol 23
(9)
◽
pp. 1320-1326
◽
1998 ◽
Vol 114
(5)
◽
pp. 988-995
◽